Multiple studies have confirmed the increased serum levels of VEGF and Angpt1 in placental trophoblastic disease and tumor patients, indicating the association of pro-angiogenesis factors with these diseases (Barak et al., 1999; Zhang et al., 2017). This evidence concerns the gene VEGFA and neoplasm.